United States Pharmaceuticals

Immune Pharmaceuticals Inc (IMNPQ)

Track

Track

Ticker: IMNPQ Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Fiorino Anthony S.
Transaction date
Sale
Price
470.80
Quantity 50,560 +45.1%
Value US$1,807,424
Fiorino Anthony S. Chief Medical Officer and COO Officer
Transaction date
Purchase
Price
247.45
Quantity 84,262 -30.8%
Value US$1,104,476
Fiorino Anthony S. Chief Medical Officer and COO Officer
Transaction date
Purchase
Price
139.13
Quantity 61,727 -11.7%
Value US$4,292,016
Kazado Daniel Non-Executive Director
Transaction date
Purchase
Price
0.19
Quantity 76,503 +7.2%
Value US$14,222
Kazado Daniel Non-Executive Director
Transaction date
Purchase
Price
0.19
Quantity 161,377 +17.8%
Value US$30,000
Teper Daniel Gedeon CEO Executive Director Large shareholder
Transaction date
Purchase
Price
0.38
Quantity 937,500 +19.5%
Value US$356,250
Luchi Monica E. EVP & CMO Officer
Transaction date
Purchase
Price
0.45
Quantity 777,778 +inf%
Value US$350,000
Kazado Daniel Non-Executive Director
Transaction date
Purchase
Price
0.45
Quantity 666,667 +277.1%
Value US$300,000
Teper Daniel Gedeon CEO Executive Director Large shareholder
Transaction date
Planned purchase
Price
0.59
Quantity 42,000 +0.9%
Value US$24,826
Teper Daniel Gedeon CEO Executive Director Large shareholder
Transaction date
Planned purchase
Price
0.57
Quantity 44,200 +0.9%
Value US$25,000
Teper Daniel Gedeon CEO Executive Director Large shareholder
Transaction date
Planned purchase
Price
0.62
Quantity 39,400 +0.8%
Value US$24,597
Teper Daniel Gedeon CEO Executive Director Large shareholder
Transaction date
Planned purchase
Price
0.81
Quantity 62,000 +1.3%
Value US$49,972
Kazado Daniel Non-Executive Director
Transaction date
Purchase
Price
0.78
Quantity 150,000 +165.5%
Value US$117,105
Teper Daniel Gedeon CEO Executive Director Large shareholder
Transaction date
Purchase
Price
0.76
Quantity 65,400 +1.4%
Value US$49,926
Kazado Daniel Non-Executive Director
Transaction date
Purchase
Price
1.47
Quantity 50,000 +123.1%
Value US$73,480
AZRIA RENE PIERRE Non-Executive Director
Transaction date
Purchase
Price
1.48
Quantity 50,000 +inf%
Value US$73,850
Teper Daniel Gedeon CEO Executive Director Large shareholder
Transaction date
Purchase
Price
1.29
Quantity 7,569 +0.2%
Value US$9,799
Stancic Ana Non-Executive Director
Transaction date
Purchase
Price
2.50
Quantity 8,000 +inf%
Value US$20,000
Berdugo Gad Non-Executive Director
Transaction date
Purchase
Price
2.50
Quantity 8,000 +inf%
Value US$20,000
Kazado Daniel Non-Executive Director
Transaction date
Purchase
Price
2.50
Quantity 8,000 +2040.8%
Value US$20,000
Durrant Cameron Non-Executive Director
Transaction date
Purchase
Price
2.50
Quantity 4,000 +inf%
Value US$10,000
SIDRANSKY DAVID Non-Executive Director
Transaction date
Purchase
Price
2.50
Quantity 10,400 +131.8%
Value US$26,000
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.36
Quantity 3,000 +4.5%
Value US$4,088
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.35
Quantity 7,000 +11.6%
Value US$9,450
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.42
Quantity 5,000 +9.1%
Value US$7,100
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.35
Quantity 5,000 +10.0%
Value US$6,750
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.44
Quantity 5,000 +11.1%
Value US$7,200
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.35
Quantity 5,000 +12.5%
Value US$6,750
COOK ROBERT W CFO-SVP, Finance & Admin. Officer
Transaction date
Purchase
Price
1.35
Quantity 5,000 +50.0%
Value US$6,750
Talley John V President, CEO & Director Executive Director
Transaction date
Purchase
Price
1.40
Quantity 15,000 +14.7%
Value US$21,000
BHAGWAT DILEEP SVP-Pharmaceutical Development Officer
Transaction date
Purchase
Price
1.42
Quantity 2,500 +25.0%
Value US$3,550
BHAGWAT DILEEP SVP-Pharmaceutical Development Officer
Transaction date
Purchase
Price
1.43
Quantity 7,500 +300.0%
Value US$10,725
Wiedemann Oliver Managing Director-See Remarks Officer
Transaction date
Purchase
Price
1.40
Quantity 5,000 +inf%
Value US$7,000
ALLARD STEPHANE Chief Medical Officer Officer
Transaction date
Purchase
Price
1.41
Quantity 10,000 +28.1%
Value US$14,100
ALLARD STEPHANE Chief Medical Officer Officer
Transaction date
Purchase
Price
1.42
Quantity 1,800 +5.3%
Value US$2,556
ALLARD STEPHANE Chief Medical Officer Officer
Transaction date
Purchase
Price
1.43
Quantity 33,200 +5533.3%
Value US$47,476
ALLARD STEPHANE Chief Medical Officer Officer
Transaction date
Purchase
Price
1.62
Quantity 600 +inf%
Value US$972
Bedard John F Non-Executive Director
Transaction date
Purchase
Price
1.68
Quantity 2,000 +inf%
Value US$3,360
COOK ROBERT W CFO-SVP, Finance & Admin. Officer
Transaction date
Purchase
Price
1.70
Quantity 903 +9.9%
Value US$1,535
COOK ROBERT W CFO-SVP, Finance & Admin. Officer
Transaction date
Purchase
Price
1.68
Quantity 900 +11.0%
Value US$1,512
COOK ROBERT W CFO-SVP, Finance & Admin. Officer
Transaction date
Purchase
Price
1.66
Quantity 8,197 +inf%
Value US$13,607
Talley John V President, CEO & Director Executive Director
Transaction date
Purchase
Price
1.65
Quantity 8,900 +9.5%
Value US$14,685
Talley John V President, CEO & Director Executive Director
Transaction date
Purchase
Price
1.64
Quantity 1,100 +1.2%
Value US$1,804
BHAGWAT DILEEP SVP-Pharmaceutical Development Officer
Transaction date
Purchase
Price
1.60
Quantity 1,500 +150.0%
Value US$2,400
BHAGWAT DILEEP SVP-Pharmaceutical Development Officer
Transaction date
Purchase
Price
1.62
Quantity 600 +150.0%
Value US$972
BHAGWAT DILEEP SVP-Pharmaceutical Development Officer
Transaction date
Purchase
Price
1.60
Quantity 400 +inf%
Value US$640
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.61
Quantity 2,000 +5.2%
Value US$3,220
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.61
Quantity 2,300 +6.4%
Value US$3,703
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.61
Quantity 2,200 +6.5%
Value US$3,542
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.56
Quantity 3,000 +9.8%
Value US$4,680
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.58
Quantity 7,000 +29.7%
Value US$11,060
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.59
Quantity 3,000 +14.6%
Value US$4,770
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.60
Quantity 3,000 +17.0%
Value US$4,800
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.61
Quantity 6,100 +53.0%
Value US$9,821
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.57
Quantity 1,100 +10.6%
Value US$1,727
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.58
Quantity 900 +9.5%
Value US$1,422
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.57
Quantity 1,000 +11.8%
Value US$1,570
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.58
Quantity 700 +9.0%
Value US$1,106
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.57
Quantity 1,000 +14.7%
Value US$1,570
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.58
Quantity 800 +13.3%
Value US$1,264
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.57
Quantity 500 +9.1%
Value US$785
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.58
Quantity 500 +10.0%
Value US$790
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.59
Quantity 1,000 +25.0%
Value US$1,590
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.57
Quantity 2,500 +166.7%
Value US$3,925
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.58
Quantity 1,000 +200.0%
Value US$1,580
SAVAGE ROBERT G Non-Executive Director
Transaction date
Purchase
Price
1.59
Quantity 500 +inf%
Value US$795
JACKSON GUY C Non-Executive Director
Transaction date
Purchase
Price
2.69
Quantity 300 +inf%
Value US$807
JACKSON GUY C Non-Executive Director
Transaction date
Purchase
Price
2.70
Quantity 4,700 +inf%
Value US$12,690
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-02-04 2020-02-03 S Sale
Fiorino Anthony S.
50,560 +45.1%
470.80
US$1,807,424 		50,560 +45.1% 470.80 US$1,807,424
2018-05-23 2018-05-22 B Purchase Fiorino Anthony S.

Chief Medical Officer and COO

Officer
84,262 -30.8%
247.45
US$1,104,476 		84,262 -30.8% 247.45 US$1,104,476
2018-05-18 2018-05-17 B Purchase Fiorino Anthony S.

Chief Medical Officer and COO

Officer
61,727 -11.7%
139.13
US$4,292,016 		61,727 -11.7% 139.13 US$4,292,016
2017-01-04 2017-01-04 B Purchase Kazado Daniel Non-Executive Director
76,503 +7.2%
0.19
US$14,222 		76,503 +7.2% 0.19 US$14,222
2016-12-20 2016-12-16 B Purchase Kazado Daniel Non-Executive Director
161,377 +17.8%
0.19
US$30,000 		161,377 +17.8% 0.19 US$30,000
2016-08-04 2016-08-04 B Purchase Teper Daniel Gedeon

CEO

Executive Director Large shareholder
937,500 +19.5%
0.38
US$356,250 		937,500 +19.5% 0.38 US$356,250
2016-08-04 2016-08-04 B Purchase Luchi Monica E.

EVP & CMO

Officer
777,778 +inf%
0.45
US$350,000 		777,778 +inf% 0.45 US$350,000
2016-08-04 2016-08-04 B Purchase Kazado Daniel Non-Executive Director
666,667 +277.1%
0.45
US$300,000 		666,667 +277.1% 0.45 US$300,000
2016-01-26 2016-01-26 PP Planned purchase Teper Daniel Gedeon

CEO

Executive Director Large shareholder
42,000 +0.9%
0.59
US$24,826 		42,000 +0.9% 0.59 US$24,826
2016-01-19 2016-01-19 PP Planned purchase Teper Daniel Gedeon

CEO

Executive Director Large shareholder
44,200 +0.9%
0.57
US$25,000 		44,200 +0.9% 0.57 US$25,000
2016-01-12 2016-01-12 PP Planned purchase Teper Daniel Gedeon

CEO

Executive Director Large shareholder
39,400 +0.8%
0.62
US$24,597 		39,400 +0.8% 0.62 US$24,597
2016-01-06 2016-01-05 PP Planned purchase Teper Daniel Gedeon

CEO

Executive Director Large shareholder
62,000 +1.3%
0.81
US$49,972 		62,000 +1.3% 0.81 US$49,972
2015-12-08 2015-12-07 B Purchase Kazado Daniel Non-Executive Director
150,000 +165.5%
0.78
US$117,105 		150,000 +165.5% 0.78 US$117,105
2015-12-08 2015-12-07 B Purchase Teper Daniel Gedeon

CEO

Executive Director Large shareholder
65,400 +1.4%
0.76
US$49,926 		65,400 +1.4% 0.76 US$49,926
2015-09-16 2015-09-14 B Purchase Kazado Daniel Non-Executive Director
50,000 +123.1%
1.47
US$73,480 		50,000 +123.1% 1.47 US$73,480
2015-09-16 2015-09-14 B Purchase AZRIA RENE PIERRE Non-Executive Director
50,000 +inf%
1.48
US$73,850 		50,000 +inf% 1.48 US$73,850
2015-09-01 2015-09-01 B Purchase Teper Daniel Gedeon

CEO

Executive Director Large shareholder
7,569 +0.2%
1.29
US$9,799 		7,569 +0.2% 1.29 US$9,799
2014-12-03 2014-11-26 B Purchase Stancic Ana Non-Executive Director
8,000 +inf%
2.50
US$20,000 		8,000 +inf% 2.50 US$20,000
2014-12-03 2014-11-26 B Purchase Berdugo Gad Non-Executive Director
8,000 +inf%
2.50
US$20,000 		8,000 +inf% 2.50 US$20,000
2014-12-03 2014-11-26 B Purchase Kazado Daniel Non-Executive Director
8,000 +2040.8%
2.50
US$20,000 		8,000 +2040.8% 2.50 US$20,000
2014-12-03 2014-11-26 B Purchase Durrant Cameron Non-Executive Director
4,000 +inf%
2.50
US$10,000 		4,000 +inf% 2.50 US$10,000
2014-12-03 2014-11-26 B Purchase SIDRANSKY DAVID Non-Executive Director
10,400 +131.8%
2.50
US$26,000 		10,400 +131.8% 2.50 US$26,000
2007-12-14 2007-12-13 B Purchase SAVAGE ROBERT G Non-Executive Director
3,000 +4.5%
1.36
US$4,088 		3,000 +4.5% 1.36 US$4,088
2007-12-14 2007-12-13 B Purchase SAVAGE ROBERT G Non-Executive Director
7,000 +11.6%
1.35
US$9,450 		7,000 +11.6% 1.35 US$9,450
2007-12-14 2007-12-13 B Purchase SAVAGE ROBERT G Non-Executive Director
5,000 +9.1%
1.42
US$7,100 		5,000 +9.1% 1.42 US$7,100
2007-12-14 2007-12-13 B Purchase SAVAGE ROBERT G Non-Executive Director
5,000 +10.0%
1.35
US$6,750 		5,000 +10.0% 1.35 US$6,750
2007-12-14 2007-12-13 B Purchase SAVAGE ROBERT G Non-Executive Director
5,000 +11.1%
1.44
US$7,200 		5,000 +11.1% 1.44 US$7,200
2007-12-14 2007-12-13 B Purchase SAVAGE ROBERT G Non-Executive Director
5,000 +12.5%
1.35
US$6,750 		5,000 +12.5% 1.35 US$6,750
2007-12-13 2007-12-13 B Purchase COOK ROBERT W

CFO-SVP, Finance & Admin.

Officer
5,000 +50.0%
1.35
US$6,750 		5,000 +50.0% 1.35 US$6,750
2007-12-13 2007-12-13 B Purchase Talley John V

President, CEO & Director

Executive Director
15,000 +14.7%
1.40
US$21,000 		15,000 +14.7% 1.40 US$21,000
2007-12-14 2007-12-12 B Purchase BHAGWAT DILEEP

SVP-Pharmaceutical Development

Officer
2,500 +25.0%
1.42
US$3,550 		2,500 +25.0% 1.42 US$3,550
2007-12-14 2007-12-12 B Purchase BHAGWAT DILEEP

SVP-Pharmaceutical Development

Officer
7,500 +300.0%
1.43
US$10,725 		7,500 +300.0% 1.43 US$10,725
2007-12-14 2007-12-12 B Purchase Wiedemann Oliver

Managing Director-See Remarks

Officer
5,000 +inf%
1.40
US$7,000 		5,000 +inf% 1.40 US$7,000
2007-12-13 2007-12-12 B Purchase ALLARD STEPHANE

Chief Medical Officer

Officer
10,000 +28.1%
1.41
US$14,100 		10,000 +28.1% 1.41 US$14,100
2007-12-13 2007-12-12 B Purchase ALLARD STEPHANE

Chief Medical Officer

Officer
1,800 +5.3%
1.42
US$2,556 		1,800 +5.3% 1.42 US$2,556
2007-12-13 2007-12-11 B Purchase ALLARD STEPHANE

Chief Medical Officer

Officer
33,200 +5533.3%
1.43
US$47,476 		33,200 +5533.3% 1.43 US$47,476
2007-12-13 2007-09-13 B Purchase ALLARD STEPHANE

Chief Medical Officer

Officer
600 +inf%
1.62
US$972 		600 +inf% 1.62 US$972
2007-09-04 2007-09-04 B Purchase Bedard John F Non-Executive Director
2,000 +inf%
1.68
US$3,360 		2,000 +inf% 1.68 US$3,360
2007-08-30 2007-08-30 B Purchase COOK ROBERT W

CFO-SVP, Finance & Admin.

Officer
903 +9.9%
1.70
US$1,535 		903 +9.9% 1.70 US$1,535
2007-08-30 2007-08-30 B Purchase COOK ROBERT W

CFO-SVP, Finance & Admin.

Officer
900 +11.0%
1.68
US$1,512 		900 +11.0% 1.68 US$1,512
2007-08-30 2007-08-29 B Purchase COOK ROBERT W

CFO-SVP, Finance & Admin.

Officer
8,197 +inf%
1.66
US$13,607 		8,197 +inf% 1.66 US$13,607
2007-08-28 2007-08-28 B Purchase Talley John V

President, CEO & Director

Executive Director
8,900 +9.5%
1.65
US$14,685 		8,900 +9.5% 1.65 US$14,685
2007-08-28 2007-08-28 B Purchase Talley John V

President, CEO & Director

Executive Director
1,100 +1.2%
1.64
US$1,804 		1,100 +1.2% 1.64 US$1,804
2007-08-27 2007-08-24 B Purchase BHAGWAT DILEEP

SVP-Pharmaceutical Development

Officer
1,500 +150.0%
1.60
US$2,400 		1,500 +150.0% 1.60 US$2,400
2007-08-24 2007-08-23 B Purchase BHAGWAT DILEEP

SVP-Pharmaceutical Development

Officer
600 +150.0%
1.62
US$972 		600 +150.0% 1.62 US$972
2007-08-24 2007-08-23 B Purchase BHAGWAT DILEEP

SVP-Pharmaceutical Development

Officer
400 +inf%
1.60
US$640 		400 +inf% 1.60 US$640
2007-08-22 2007-08-21 B Purchase SAVAGE ROBERT G Non-Executive Director
2,000 +5.2%
1.61
US$3,220 		2,000 +5.2% 1.61 US$3,220
2007-08-22 2007-08-21 B Purchase SAVAGE ROBERT G Non-Executive Director
2,300 +6.4%
1.61
US$3,703 		2,300 +6.4% 1.61 US$3,703
2007-08-22 2007-08-21 B Purchase SAVAGE ROBERT G Non-Executive Director
2,200 +6.5%
1.61
US$3,542 		2,200 +6.5% 1.61 US$3,542
2007-08-22 2007-08-21 B Purchase SAVAGE ROBERT G Non-Executive Director
3,000 +9.8%
1.56
US$4,680 		3,000 +9.8% 1.56 US$4,680
2007-08-22 2007-08-21 B Purchase SAVAGE ROBERT G Non-Executive Director
7,000 +29.7%
1.58
US$11,060 		7,000 +29.7% 1.58 US$11,060
2007-08-22 2007-08-21 B Purchase SAVAGE ROBERT G Non-Executive Director
3,000 +14.6%
1.59
US$4,770 		3,000 +14.6% 1.59 US$4,770
2007-08-22 2007-08-21 B Purchase SAVAGE ROBERT G Non-Executive Director
3,000 +17.0%
1.60
US$4,800 		3,000 +17.0% 1.60 US$4,800
2007-08-22 2007-08-21 B Purchase SAVAGE ROBERT G Non-Executive Director
6,100 +53.0%
1.61
US$9,821 		6,100 +53.0% 1.61 US$9,821
2007-08-21 2007-08-20 B Purchase SAVAGE ROBERT G Non-Executive Director
1,100 +10.6%
1.57
US$1,727 		1,100 +10.6% 1.57 US$1,727
2007-08-21 2007-08-20 B Purchase SAVAGE ROBERT G Non-Executive Director
900 +9.5%
1.58
US$1,422 		900 +9.5% 1.58 US$1,422
2007-08-21 2007-08-20 B Purchase SAVAGE ROBERT G Non-Executive Director
1,000 +11.8%
1.57
US$1,570 		1,000 +11.8% 1.57 US$1,570
2007-08-21 2007-08-20 B Purchase SAVAGE ROBERT G Non-Executive Director
700 +9.0%
1.58
US$1,106 		700 +9.0% 1.58 US$1,106
2007-08-21 2007-08-20 B Purchase SAVAGE ROBERT G Non-Executive Director
1,000 +14.7%
1.57
US$1,570 		1,000 +14.7% 1.57 US$1,570
2007-08-21 2007-08-20 B Purchase SAVAGE ROBERT G Non-Executive Director
800 +13.3%
1.58
US$1,264 		800 +13.3% 1.58 US$1,264
2007-08-21 2007-08-20 B Purchase SAVAGE ROBERT G Non-Executive Director
500 +9.1%
1.57
US$785 		500 +9.1% 1.57 US$785
2007-08-21 2007-08-20 B Purchase SAVAGE ROBERT G Non-Executive Director
500 +10.0%
1.58
US$790 		500 +10.0% 1.58 US$790
2007-08-21 2007-08-20 B Purchase SAVAGE ROBERT G Non-Executive Director
1,000 +25.0%
1.59
US$1,590 		1,000 +25.0% 1.59 US$1,590
2007-08-20 2007-08-17 B Purchase SAVAGE ROBERT G Non-Executive Director
2,500 +166.7%
1.57
US$3,925 		2,500 +166.7% 1.57 US$3,925
2007-08-20 2007-08-17 B Purchase SAVAGE ROBERT G Non-Executive Director
1,000 +200.0%
1.58
US$1,580 		1,000 +200.0% 1.58 US$1,580
2007-08-20 2007-08-17 B Purchase SAVAGE ROBERT G Non-Executive Director
500 +inf%
1.59
US$795 		500 +inf% 1.59 US$795
2006-06-15 2006-06-13 B Purchase JACKSON GUY C Non-Executive Director
300 +inf%
2.69
US$807 		300 +inf% 2.69 US$807
2006-06-15 2006-06-13 B Purchase JACKSON GUY C Non-Executive Director
4,700 +inf%
2.70
US$12,690 		4,700 +inf% 2.70 US$12,690
Explore more

More insider trading research around Immune Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America